| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02279342 Details | 2017-08-03 Interventional | 4 | 1 | Febuxostat Angina, Stable Coronary Artery… Coronary Diseas… Hyperuricemia Myocardial Isch… | Entry were insufficient as expected. - | |||
| NCT02429076 Details | 2017-08-02 Interventional | 1/2 | 0 | Methylphenidate Propofol Sevoflurane Active Emergenc… | We are not going to complete this study with healthy volunteers at this time. - | |||
| NCT02316496 Details | 2017-08-01 Interventional | 2 | 2 | Cetuximab Irinotecan Colorectal Neop… Colorectal Canc… | - - | |||
| NCT00386516 Details | 2017-08-01 Interventional | 2 | 0 | Fluorouracil Bile Duct Neopl… Gallbladder Neo… Cancer of the B… Gallbladder Can… | Financing and re-organization - | |||
| NCT00381810 Details | 2017-08-01 Interventional | 3 | 31 | Acetaminophen Diphenhydramine Methylprednisol… Promethazine Rituximab Lupus Erythemat… | During a safety review of studies U2970g and U2971g, the Data Monitoring Committee recommended
that enrollment in this extension trial be terminated. Since study U2971g did not demonstrate efficacy, a decision was made not to evaluate efficacy in this study and only safety results were evaluated. | |||
| NCT00089778 NCT00091403 Details | 2017-08-01 Interventional | 2 | 11 | Aldesleukin Interleukin-2 Mitogens Carcinoma, Rena… Kidney Neoplasm… Kidney Cancer | fewer tumors than expected expressed FGF-5, led to end of accrual to cohorts A&B - | |||
| NCT02442674 Details | 2017-07-31 Interventional | 3 | 0 | Tolvaptan Hyponatremia | Trial withdrawn due to inability to meet the trial objectives (Pilot). - | |||
| NCT02674555 Details | 2017-07-28 Interventional | 1 | 0 | Naquotinib Neoplasms Epidermal Growt… Solid Tumors | Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies. - | |||
| NCT01856517 Details | 2017-07-28 Interventional | 2/3 | - | Clonidine Shock Shock, Septic Septic Shock | - - | |||
| NCT02651727 Details | 2017-07-27 Interventional | 1 | 13 | Albumin-Bound P… Gemcitabine Paclitaxel Pancreatic Canc… | the company's decision to de-prioritize 4718 development - | |||
| NCT01764997 2012-001984-66 Details | 2017-07-27 Interventional | 3 | 776 | Adalimumab Etanercept Methotrexate Arthritis Arthritis, Rheu… Rheumatoid Arth… | Due to small number of participants entering randomization. Not a safety issue. The study was prematurely terminated due to small number of participants entering randomization. | |||
| NCT02563782 Details | 2017-07-26 Interventional | 2 | 0 | Mycophenolic Ac… Tacrolimus Macular Degener… Age-Related Mac… | Changes to the study design and the cell line - | |||
| NCT01260103 Details | 2017-07-26 Interventional | 3 | 0 | Temozolomide Glioma Optic Nerve Gli… | Withdrawn: study halted prematurely, prior to enrollment of first participant - | |||
| NCT00590135 Details | 2017-07-26 Interventional | 4 | 59 | Atorvastatin Aortic Valve St… Constriction, P… | Poor Reducibility - primary endpoint measure not obtainable - | |||
| NCT03216876 Details | 2017-07-25 Interventional | 1 | 0 | Ursolic Acid Cholangitis Cholangitis, Sc… Primary Scleros… | Lack of feasibility - | |||
| NCT02191748 Details | 2017-07-25 Interventional | 2/3 | 22 | Triamcinolone Vitiligo | Principal investigator made the decision to close study and not submit a renewal. Lack of fixed
research personnel to carry out the study effectively. - | |||
| NCT00695643 2007-000680-22 Details | 2017-07-24 Interventional | 3 | [3 Refs] | 345 | Mesalamine Diverticulitis Recurrence | - - | ||
| NCT03137030 Details | 2017-07-21 Interventional | 1 | 0 | Acetaminophen Hydrocodone Acute Pain Opioid-Related … Pain, Postopera… Pain, Acute | program discontinued - | |||
| NCT03137017 Details | 2017-07-21 Interventional | 1 | 0 | Acetaminophen Hydrocodone Acute Pain Opioid-Related … Pain, Postopera… Pain, Acute | program discontinued - | |||
| NCT02732327 Details | 2017-07-21 Interventional | 2 | 2 | Cefepime Linezolid Meropenem Piperacillin Piperacillin, T… Tazobactam Vancomycin Febrile Neutrop… Fever Hyperthermia Neutropenia Neoplasms | No longer aligned with the revised clinical development plan and commercial strategy - |